Home/Filings/4/0002092127-25-000004
4//SEC Filing

Wasfi Yasmine 4

Accession 0002092127-25-000004

CIK 0001160308other

Filed

Oct 21, 8:00 PM ET

Accepted

Oct 22, 8:47 PM ET

Size

7.6 KB

Accession

0002092127-25-000004

Insider Transaction Report

Form 4
Period: 2025-10-20
Wasfi Yasmine
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2025-10-20+35,000190,000 total
  • Award

    Stock Option (Right to Buy)

    2025-10-20+70,00070,000 total
    Exercise: $4.11Exp: 2035-10-20Common Stock (70,000 underlying)
Footnotes (2)
  • [F1]Represents restricted stock units ("RSUs") that vest in full on October 17, 2027, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of October 17, 2025, subject to the reporting person's continued service with the Issuer.

Documents

1 file

Issuer

Savara Inc

CIK 0001160308

Entity typeother

Related Parties

1
  • filerCIK 0002092127

Filing Metadata

Form type
4
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 8:47 PM ET
Size
7.6 KB